Michael Zaworotko

Title: Michael Zaworotko: Pioneering Innovations in Cocrystal Compounds

Introduction

Michael Zaworotko is a renowned inventor based in Limerick, Ireland, known for his contributions to the field of pharmaceutical cocrystal compounds. With a remarkable portfolio of 8 patents, he has established himself as a leading figure in the development of innovative materials that enhance drug performance.

Latest Patents

Among his latest patents are significant advancements in the area of organic anion lithium ionic cocrystal compounds and compositions. His work includes the formulation of cocrystals with the formula LiX·aM, where X represents the conjugate base of an organic acid and M is a neutral organic molecule. These compounds are designed to improve the pharmacological properties of treatments. Furthermore, Zaworotko's research on co-crystal compounds comprising lithium ions and isonicotinamide has produced stable crystal forms that exhibit superior in vivo performance compared to conventional lithium carbonate.

Career Highlights

Michael Zaworotko's academic journey includes collaborations with prominent institutions such as the University of South Florida and the University of Limerick. His innovative research has been instrumental in advancing the understanding of cocrystal technology, bridging the gap between chemistry and pharmaceutical applications.

Collaborations

Throughout his career, Zaworotko has collaborated with esteemed colleagues, including Naga Duggirala and Adam John Smith. Their collective expertise has played a pivotal role in the successful development of his groundbreaking patents.

Conclusion

Michael Zaworotko's contributions to the field of cocrystal compounds are revolutionizing the pharmaceutical landscape. His inventive spirit and dedication to research continue to inspire future innovations and improve drug delivery methods, solidifying his legacy as a prominent inventor.